p-Aminosalicylic acid in tuberculosis.

A. Erdei

DOI: https://doi.org/10.1016/s0140-6736(49)90147-6

IF: 202.731

The Lancet

Abstract:

What problem does this paper attempt to address?

Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis

Maria Jalbrzikowski,Rebecca A. Hayes,Stephen J. Wood,Dorte Nordholm,Juan H. Zhou,Paolo Fusar-Poli,Peter J. Uhlhaas,Tsutomu Takahashi,Gisela Sugranyes,Yoo Bin Kwak,Daniel H. Mathalon,Naoyuki Katagiri,Christine I. Hooker,Lukasz Smigielski,Tiziano Colibazzi,Esther Via,Jinsong Tang,Shinsuke Koike,Paul E. Rasser,Chantal Michel,Irina Lebedeva,Wenche ten Velden Hegelstad,Camilo de la Fuente-Sandoval,James A. Waltz,Romina R.M. Mizrahi,Cheryl Corcoran,Franz Resch,Christian K. Tamnes,Shalaila S. Haas,Imke L.J. Lemmers-Jansen,Ingrid Agartz,Paul Allen,Ole A. Andreassen,Kimberley Atkinson,Peter Bachman,Inmaculada Baeza,Helen Baldwin,Cali F. Bartholomeusz,Kolbjørn S. Brønnick,Sabrina Catalano,Michael W.L. Chee,Xiaogang Chen,Kang Ik K. Cho,Rebecca E. Cooper,Vanessa L. Cropley,Montserrat Dolz,Bjørn H. Ebdrup,Adriana Fortea,Louise B. Glenthøj,Birte Y. Glenthøj,Lieuwe de Haan,Holly K. Hamilton,Mathew A. Harris,Kristen M. Haut,Ying He,Karsten Heekeren,Andreas Heinz,Daniela Hubl,Wu Jeong Hwang,Michael Kaess,Kiyoto Kasai,Minah Kim,Jochen Kindler,Mallory J. Klaunig,Tina D. Kristensen,Jun Soo Kwon,Stephen M. Lawrie,Jimmy Lee,Pablo León-Ortiz,Ashleigh Lin,Rachel L. Loewy,Xiaoqian Ma,Patrick McGorry,Philip McGuire,Masafumi Mizuno,Paul Møller,Toma Moncada-Habib,Daniel Munoz-Samons,Barnaby Nelson,Takahiro Nemoto,Merete Nordentoft,Maria A. Omelchenko,Ketil Oppedal,Lijun Ouyang,Christos Pantelis,Jose C. Pariente,Jayachandra Raghava,Francisco Reyes-Madrigal,Brian J. Roach,Jan I. Røssberg,Wulf Rössler,Dean F. Salisbury,Daiki Sasabayashi,Ulrich Schall,Jason Schiffman,Florian Schlagenhauf,Andre Schmidt,Mikkel E. Sørensen,Michio Suzuki,Anastasia Theodoridou,Alexander S. Tomyshev,Jordina Tor,Tor G Vaernes,Dennis Velakoulis,Gloria D. Venegoni,Sophia Vinogradov,Christina Wenneberg,Lars T. Westlye,Hidenori Yamasue,Liu Yuan,Alison R. Yung,Thérèse A.M.J. van Amelsvoort,Jessica A. Turner,Theo G.M. van Erp,Paul M. Thompson,Dennis Hernaus,Koppel,Borgwardt

DOI: https://doi.org/10.1101/2021.01.05.20248768

2021-01-01

MedRxiv

Abstract:Abstract Importance: The ENIGMA clinical high risk for psychosis (CHR) initiative, the largest pooled CHR-neuroimaging sample to date, aims to discover robust neurobiological markers of psychosis risk in a sample with known heterogeneous outcomes. Objective: We investigated baseline structural neuroimaging differences between CHR subjects and healthy controls (HC), and between CHR participants who later developed a psychotic disorder (CHR-PS+) and those who did not (CHR-PS-). We assessed associations with age by group and conversion status, and similarities between the patterns of effect size maps for psychosis conversion and those found in other large-scale psychosis studies. Design, Setting, and Participants. Baseline T1-weighted MRI data were pooled from 31 international sites participating in the ENIGMA CHR Working Group. MRI scans were processed using harmonized protocols and analyzed within a mega- and meta-analysis framework from January-October 2020. Main Outcome(s) and Measure(s): Measures of regional cortical thickness (CT), surface area (SA), and subcortical volumes were extracted from T1-weighted MRI scans. Independent variables were group (CHR, HC) and conversion status (CHR-PS+, CHR-PS-, HC). Results: The final dataset consisted of 3,169 participants (CHR=1,792, HC=1,377, age range: 9.5 to 39.8 years, 45% female). Using longitudinal clinical information, we identified CHR-PS+ (N=253) and CHR-PS- (N=1,234). CHR exhibited widespread thinner cortex compared to HC (average d=-0.125, range: -0.09 to -0.17), but not SA or subcortical volume. Thinner cortex in the fusiform, superior temporal, and paracentral regions was associated with psychosis conversion (average d=-0.22). Age showed a stronger negative association with left fusiform and left paracentral CT in HC, compared to CHR-PS+. Regional CT psychosis conversion effect sizes resembled patterns of CT alterations observed in other ENIGMA studies of psychosis. Conclusions and Relevance: We provide evidence for widespread subtle CT reductions in CHR. The pattern of regions displaying greater CT alterations in CHR-PS+ were similar to those reported in other large-scale investigations of psychosis. Additionally, a subset of these regions displayed abnormal age associations. Widespread CT disruptions coupled with abnormal age associations in CHR may point to disruptions in postnatal brain developmental processes.
Association of Structural Magnetic Resonance Imaging Measures with Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: an ENIGMA Working Group Mega-analysis.

Maria Jalbrzikowski,Rebecca A. Hayes,Stephen J. Wood,Dorte Nordholm,Juan H. Zhou,Paolo Fusar-Poli,Peter J. Uhlhaas,Tsutomu Takahashi,Gisela Sugranyes,Yoo Bin Kwak,Daniel H. Mathalon,Naoyuki Katagiri,Christine I. Hooker,Lukasz Smigielski,Tiziano Colibazzi,Esther Via,Jinsong Tang,Shinsuke Koike,Paul E. Rasser,Chantal Michel,Irina Lebedeva,Wenche ten Velden Hegelstad,Camilo de la Fuente-Sandoval,James A. Waltz,Romina Mizrahi,Cheryl M. Corcoran,Franz Resch,Christian K. Tamnes,Shalaila S. Haas,Imke L. J. Lemmers-Jansen,Ingrid Agartz,Paul Allen,G. Paul Amminger,Ole A. Andreassen,Kimberley Atkinson,Peter Bachman,Inmaculada Baeza,Helen Baldwin,Cali F. Bartholomeusz,Stefan Borgwardt,Sabrina Catalano,Michael W. L. Chee,Xiaogang Chen,Kang Ik K. Cho,Rebecca E. Cooper,Vanessa L. Cropley,Montserrat Dolz,Bjorn H. Ebdrup,Adriana Fortea,Louise Birkedal Glenthoj,Birte Y. Glenthoj,Lieuwe de Haan,Holly K. Hamilton,Mathew A. Harris,Kristen M. Haut,Ying He,Karsten Heekeren,Andreas Heinz,Daniela Hubl,Wu Jeong Hwang,Michael Kaess,Kiyoto Kasai,Minah Kim,Jochen Kindler,Mallory J. Klaunig,Alex Koppel,Tina D. Kristensen,Jun Soo Kwon,Stephen M. Lawrie,Jimmy Lee,Pablo Leon-Ortiz,Ashleigh Lin,Rachel L. Loewy,Xiaoqian Ma,Patrick McGorry,Philip McGuire,Masafumi Mizuno,Paul Moller,Tomas Moncada-Habib,Daniel Munoz-Samons,Barnaby Nelson,Takahiro Nemoto,Merete Nordentoft,Maria A. Omelchenko,Ketil Oppedal,Lijun Ouyang,Christos Pantelis,Jose C. Pariente,Jayachandra M. Raghava,Francisco Reyes-Madrigal,Brian J. Roach,Jan I. Rossberg,Wulf Rossler,Dean F. Salisbury,Daiki Sasabayashi,Ulrich Schall,Jason Schiffman,Florian Schlagenhauf,Andre Schmidt,Mikkel E. Sorensen,Michio Suzuki,Anastasia Theodoridou,Alexander S. Tomyshev,Jordina Tor,Tor G. Vaernes,Dennis Velakoulis,Gloria D. Venegoni,Sophia Vinogradov,Christina Wenneberg,Lars T. Westlye,Hidenori Yamasue,Liu Yuan,Alison R. Yung,Therese A. M. J. van Amelsvoort,Jessica A. Turner,Theo G. M. van Erp,Paul M. Thompson,Dennis Hernaus

DOI: https://doi.org/10.1001/jamapsychiatry.2021.0638

2021-01-01

JAMA Psychiatry

Abstract:Importance:The ENIGMA clinical high risk (CHR) for psychosis initiative, the largest pooled neuroimaging sample of individuals at CHR to date, aims to discover robust neurobiological markers of psychosis risk.Objective:To investigate baseline structural neuroimaging differences between individuals at CHR and healthy controls as well as between participants at CHR who later developed a psychotic disorder (CHR-PS+) and those who did not (CHR-PS-).Design, Setting, and Participants:In this case-control study, baseline T1-weighted magnetic resonance imaging (MRI) data were pooled from 31 international sites participating in the ENIGMA Clinical High Risk for Psychosis Working Group. CHR status was assessed using the Comprehensive Assessment of At-Risk Mental States or Structured Interview for Prodromal Syndromes. MRI scans were processed using harmonized protocols and analyzed within a mega-analysis and meta-analysis framework from January to October 2020.Main Outcomes and Measures:Measures of regional cortical thickness (CT), surface area, and subcortical volumes were extracted from T1-weighted MRI scans. Independent variables were group (CHR group vs control group) and conversion status (CHR-PS+ group vs CHR-PS- group vs control group).Results:Of the 3169 included participants, 1428 (45.1%) were female, and the mean (SD; range) age was 21.1 (4.9; 9.5-39.9) years. This study included 1792 individuals at CHR and 1377 healthy controls. Using longitudinal clinical information, 253 in the CHR-PS+ group, 1234 in the CHR-PS- group, and 305 at CHR without follow-up data were identified. Compared with healthy controls, individuals at CHR exhibited widespread lower CT measures (mean [range] Cohen d = -0.13 [-0.17 to -0.09]), but not surface area or subcortical volume. Lower CT measures in the fusiform, superior temporal, and paracentral regions were associated with psychosis conversion (mean Cohen d = -0.22; 95% CI, -0.35 to 0.10). Among healthy controls, compared with those in the CHR-PS+ group, age showed a stronger negative association with left fusiform CT measures (F = 9.8; P < .001; q < .001) and left paracentral CT measures (F = 5.9; P = .005; q = .02). Effect sizes representing lower CT associated with psychosis conversion resembled patterns of CT differences observed in ENIGMA studies of schizophrenia (ρ = 0.35; 95% CI, 0.12 to 0.55; P = .004) and individuals with 22q11.2 microdeletion syndrome and a psychotic disorder diagnosis (ρ = 0.43; 95% CI, 0.20 to 0.61; P = .001).Conclusions and Relevance:This study provides evidence for widespread subtle, lower CT measures in individuals at CHR. The pattern of CT measure differences in those in the CHR-PS+ group was similar to those reported in other large-scale investigations of psychosis. Additionally, a subset of these regions displayed abnormal age associations. Widespread disruptions in CT coupled with abnormal age associations in those at CHR may point to disruptions in postnatal brain developmental processes.
Clinical and neurodevelopmental predictors of psychotic disorders in children and adolescents at clinical high risk for psychosis: the CAPRIS study

Montserrat Dolz,Jordina Tor,Olga Puig,Elena de la Serna,Daniel Muñoz-Samons,Marta Pardo,Xavier Alvarez-Subiela,Marta Rodriguez-Pascual,Gisela Sugranyes,Daniel Ilzarbe,Inmaculada Baeza

DOI: https://doi.org/10.1007/s00787-024-02436-4

2024-04-21

European Child & Adolescent Psychiatry

Abstract:Background The neurodevelopmental hypothesis of schizophrenia represents the disorder as an expression of an alteration during the brain development process early in life. Neurodevelopmental variables could become a trait marker, and the study of these variables in children and adolescents at clinical high risk for psychosis (CHR) could identify a specific cluster of patients who later developed psychosis. The aim of this study is to describe clinical and neurodevelopment predictors of transition to psychosis in child and adolescent participants at CHR. Naturalistic longitudinal two-center study of 101 CHR and 110 healthy controls (HC) aged 10–17. CHR participants were children and adolescents aged 10–17, meeting one or more of the CHR criteria assessed at baseline and at 18 months' follow-up. Neurodevelopmental variables assessed were obstetric complications, delay in principal development milestones, and presence of a neurodevelopment diagnosis. Pairwise comparisons, linear regressions, and binary logistic regression were performed.A transition rate of 23.3% at 1.5 years was observed. Participants who developed psychosis (CHR-P) showed higher rates of grandiosity and higher proportions of antipsychotic medication intake at baseline compared to participants who did not develop a psychotic disorder (CHR-NP). In terms of neurodevelopment alterations, CHR-P group showed a higher proportion of participants reporting delay in language development than the CHR-NP and HC groups. The odds of psychosis increased by 6.238 CI 95% [1.276–30.492] for a one-unit increase in having a positive score in grandiosity; they increased by 4.257 95% CI [1.293–14.023] for a one-unit increase in taking antipsychotic medication, and by 4.522 95% [1.185–64.180] for showing language development delay. However, the p-values did not reach significance after adjusting for multiple comparisons.A combination of clinical and neurodevelopmental alterations could help predict the transition to psychotic disorder in a CHR child and adolescent sample. Our results suggest the potential utility of collecting information about neurodevelopment and using these variable multifactorial models to predict psychosis disorders.

pediatrics,psychiatry,psychology, developmental
Free Long-Acting Injectables for Patients with Psychosis: A Step Forward.

Ling-Zhuo Kong,Yu-Ting Shen,Dan-Hua Zhang,Jian-Bo Lai,Shao-Hua Hu

DOI: https://doi.org/10.1016/j.ajp.2023.103476

IF: 13.89

2023-01-01

Asian Journal of Psychiatry

Abstract:Cognitive abilities are markers of brain development and psychopathology. Abilities, across executive, and social domains need better characterization over development, including factors that influence developmental change. This study is based on the cVEDA [Consortium on Vulnerability to Externalizing Disorders and Addictions] study, an Indian population based developmental cohort. Verbal working memory, visuo-spatial working memory, response inhibition, set-shifting, and social cognition (faux pas recognition and emotion recognition) were cross-sectionally assessed in > 8000 individuals over the ages 6–23 years. There was adequate representation across sex, urban-rural background, psychosocial risk (psychopathology, childhood adversity and wealth index, i.e. socio-economic status). Quantile regression was used to model developmental change. Age-based trajectories were generated, along with examination of the impact of determinants (sex, childhood adversity, and wealth index).Development in both executive and social cognitive abilities continued into adulthood. Maturation and stabilization occurred in increasing order of complexity, from working memory to inhibitory control to cognitive flexibility. Age related change was more pronounced for low quantiles in response inhibition (β∼4 versus =2 for higher quantiles), but for higher quantiles in set-shifting (β > −1 versus −0.25 for lower quantiles). Wealth index had the largest influence on developmental change across cognitive abilities. Sex differences were prominent in response inhibition, set-shifting and emotion recognition. Childhood adversity had a negative influence on cognitive development. These findings add to the limited literature on patterns and determinants of cognitive development. They have implications for understanding developmental vulnerabilities in young persons, and the need for providing conducive socio-economic environments.
Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program

Guusje Collin,Larry J. Seidman,Matcheri S. Keshavan,William S. Stone,Zhenghan Qi,Tianhong Zhang,Yingying Tang,Huijun Li,Sheeba Arnold Anteraper,Margaret A. Niznikiewicz,Robert W. McCarley,Martha E. Shenton,Jijun Wang,Susan Whitfield-Gabrieli

DOI: https://doi.org/10.1038/s41380-018-0288-x

IF: 11

2018-11-08

Molecular Psychiatry

Abstract:The emergence of prodromal symptoms of schizophrenia and their evolution into overt psychosis may stem from an aberrant functional reorganization of the brain during adolescence. To examine whether abnormalities in connectome organization precede psychosis onset, we performed a functional connectome analysis in a large cohort of medication-naive youth at risk for psychosis from the Shanghai At Risk for Psychosis (SHARP) study. The SHARP program is a longitudinal study of adolescents and young adults at Clinical High Risk (CHR) for psychosis, conducted at the Shanghai Mental Health Center in collaboration with neuroimaging laboratories at Harvard and MIT. Our study involved a total of 251 subjects, including 158 CHRs and 93 age-, sex-, and education-matched healthy controls. During 1-year follow-up, 23 CHRs developed psychosis. CHRs who would go on to develop psychosis were found to show abnormal modular connectome organization at baseline, while CHR non-converters did not. In all CHRs, abnormal modular connectome organization at baseline was associated with a threefold conversion rate. A region-specific analysis showed that brain regions implicated in early-course schizophrenia, including superior temporal gyrus and anterior cingulate cortex, were most abnormal in terms of modular assignment. Our results show that functional changes in brain network organization precede the onset of psychosis and may drive psychosis development in at-risk youth.

biochemistry & molecular biology,neurosciences,psychiatry
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?

Gregory A Light,Neal R Swerdlow,Gregory A. Light,Neal R. Swerdlow

DOI: https://doi.org/10.1176/appi.ajp.20240100

IF: 17.7

2024-04-03

American Journal of Psychiatry

Abstract:The challenges of early identification and treatment of individuals with psychotic disorders are substantial. Among the heterogeneous groups of teens identified as being at high risk for psychosis, based on clinical manifestations established by interviews and scales, only about 1 out of 4 individuals actually converts to a chronic psychotic disorder (1). This 75% "false positive" rate reflects both the complex interplay of neurological and psychological development during transitional ages and highlights the limits of resolution of the clinical interviews designed to identify psychosis "proneness." The need for better prediction with actionable follow-up has driven the search for neurocognitive, neuroimaging, and neurophysiological biomarkers, among others (2). And because even the best biomarkers add only modestly to predictive accuracy for psychosis, "conversion calculators" have been tasked with applying algorithms to draw from the predictive power across multiple different biomarkers (3). Our field has fully embraced the notion that early identification and treatment are the keys to preventing the destructive arc of the schizophrenias, and has progressed from the sole reliance on imprecise clinical scales to the hope of applying direct and reliable brain-based biomarkers to prediction algorithms to bend this curve.

psychiatry
Symptom Dimensions and Cognitive Impairments in Individuals at Clinical High Risk for Psychosis

Tian Hong Zhang,Li Hua Xu,Yan Yan Wei,HuiRu Cui,Xiao Chen Tang,Ye Gang Hu,Hai Chun Liu,Zi Xuan Wang,Tao Chen,Zheng Hui Yi,Chun Bo Li,Ji Jun Wang

DOI: https://doi.org/10.1016/j.bpsc.2024.09.002

2024-09-13

Abstract:Objective: Understanding the intricate relationship between symptom dimensions, clusters, and cognitive impairments is crucial for early detection and intervention in individuals at clinical high-risk(CHR) for psychosis. This study delves into this complex interplay within a CHR sample and aims to predict the conversion to psychosis. Methods: A comprehensive cognitive assessment was performed among 744 CHR individuals. The study included a three-year follow-up period to assess conversion to psychosis. Symptom profiles were determined using the Structured Interview for Prodromal Syndromes. By applying factor analysis, symptom dimensions were categorized as dominant negative symptoms(NS), positive symptoms-stressful(PS-S), and positive symptoms-odd(PS-O). The factor scores were used to define three dominant symptom groups. Latent class analysis(LCA) and factor mixture model(FMM) were employed to identify discrete clusters based on symptom patterns. The three-class solution was chosen for the LCA and FMM analysis. Results: Individuals in the dominant NS group exhibited significantly higher conversion rates to psychosis than those in the other groups. Specific cognitive variables, including performance in the Brief Visuospatial Memory Test-Revised(Odd ratio, OR=0.702, p=0.001) and Neuropsychological Assessment Battery mazes(OR=0.776, p=0.024), significantly predicted conversion to psychosis. Notably, cognitive impairments associated with NS and PS-S affected different cognitive domains. LCA- and FMM-Cluster 1, characterized by severe NS and PS-O, exhibited more impairments in cognitive domains than other clusters. No significant difference in the conversion rate was observed among LCA and FMM clusters. Conclusions: These findings highlight the importance of NS in the development of psychosis and suggest specific cognitive domains that are affected by symptom dimensions.
Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study

Jonah F Byrne,Colm Healy,Melanie Föcking,Subash Raj Susai,David Mongan,Kieran Wynne,Eleftheria Kodosaki,Meike Heurich,Lieuwe de Haan,Ian B Hickie,Stefan Smesny,Andrew Thompson,Connie Markulev,Alison Ruth Young,Miriam R Schäfer,Anita Riecher-Rössler,Nilufar Mossaheb,Gregor Berger,Monika Schlögelhofer,Merete Nordentoft,Eric Y H Chen,Swapna Verma,Dorien H Nieman,Scott W Woods,Barbara A Cornblatt,William S Stone,Daniel H Mathalon,Carrie E Bearden,Kristin S Cadenhead,Jean Addington,Elaine F Walker,Tyrone D Cannon,Mary Cannon,Pat McGorry,Paul Amminger,Gerard Cagney,Barnaby Nelson,Clark Jeffries,Diana Perkins,David R Cotter

DOI: https://doi.org/10.1093/schbul/sbad184

2024-01-19

Schizophrenia Bulletin

Abstract:Abstract Psychosis risk prediction is one of the leading challenges in psychiatry. Previous investigations have suggested that plasma proteomic data may be useful in accurately predicting transition to psychosis in individuals at clinical high risk (CHR). We hypothesized that an a priori-specified proteomic prediction model would have strong predictive accuracy for psychosis risk and aimed to replicate longitudinal associations between plasma proteins and transition to psychosis. This study used plasma samples from participants in 3 CHR cohorts: the North American Prodrome Longitudinal Studies 2 and 3, and the NEURAPRO randomized control trial (total n = 754). Plasma proteomic data were quantified using mass spectrometry. The primary outcome was transition to psychosis over the study follow-up period. Logistic regression models were internally validated, and optimism-corrected performance metrics derived with a bootstrap procedure. In the overall sample of CHR participants (age: 18.5, SD: 3.9; 51.9% male), 20.4% (n = 154) developed psychosis within 4.4 years. The a priori-specified model showed poor risk-prediction accuracy for the development of psychosis (C-statistic: 0.51 [95% CI: 0.50, 0.59], calibration slope: 0.45). At a group level, Complement C8B, C4B, C5, and leucine-rich α-2 glycoprotein 1 (LRG1) were associated with transition to psychosis but did not surpass correction for multiple comparisons. This study did not confirm the findings from a previous proteomic prediction model of transition from CHR to psychosis. Certain complement proteins may be weakly associated with transition at a group level. Previous findings, derived from small samples, should be interpreted with caution.

psychiatry
Neurocognitive profiles in the prodrome to psychosis in NAPLS-1

Eva Velthorst,Eric C. Meyer,Anthony J. Giuliano,Jean Addington,Kristin S. Cadenhead,Tyrone D. Cannon,Barbara A. Cornblatt,Thomas H. McGlashan,Diana O. Perkins,Ming T. Tsuang,Elaine F. Walker,Scott W. Woods,Carrie E. Bearden,Larry J. Seidman,Eva Velthorst,Jean Addington

DOI: https://doi.org/10.1016/j.schres.2018.07.038

IF: 4.662

2019-02-01

Schizophrenia Research

Abstract:BACKGROUND: Most studies of neurocognitive functioning in Clinical High Risk (CHR) cohorts have examined group averages, likely concealing heterogeneous subgroups. We aimed to identify neurocognitive subgroups and to explore associated outcomes.METHODS: Data were acquired from 324 participants (mean age 18.4) in the first phase of the North American Prodrome Longitudinal Study (NAPLS-1), a multi-site consortium following individuals for up to 2 1/2 years. We applied Ward's method for hierarchical clustering data to 8 baseline neurocognitive measures, in 166 CHR individuals, 49 non-CHR youth with a family history of psychosis, and 109 healthy controls. We tested whether cluster membership was associated with conversion to psychosis, social and role functioning, and follow-up diagnosis. Analyses were repeated after data were clustered based on independently developed clinical decision rules.RESULTS: Four neurocognitive clusters were identified: Significantly Impaired (n = 33); Mildly Impaired (n = 82); Normal (n = 145) and High (n = 64). The Significantly Impaired subgroup demonstrated the largest deviations on processing speed and memory tasks and had a conversion rate of 58%, a 40% chance of developing a schizophrenia spectrum diagnosis (compared to 24.4% in the Mildly Impaired, and 10.3% in the other two groups combined), and significantly worse functioning at baseline and 12-months. Data clustered using clinical decision rules yielded similar results, pointing to high convergent validity.CONCLUSION: Neurocognitive profiles vary substantially in their severity and are associated with diagnostic and functional outcome, underscoring neurocognition as a predictor of illness outcomes. These findings, if replicated, are a first step toward personalized treatment for individuals at-risk for psychosis.

psychiatry
Timeframe for Conversion to Psychosis From Individuals at Clinical High-Risk: A Quantile Regression

TianHong Zhang,YanYan Wei,XiaoChen Tang,LiHua Xu,YeGang Hu,HaiChun Liu,ZiXuan Wang,Tao Chen,ChunBo Li,JiJun Wang

DOI: https://doi.org/10.1093/schbul/sbae129

2024-07-25

Abstract:Background and hypothesis: The time taken for an individual who is at the clinical high-risk (CHR) stage to transition to full-blown psychosis may vary from months to years. This temporal aspect, known as the timeframe for conversion to psychosis (TCP), is a crucial but relatively underexplored dimension of psychosis development. Study design: The sample consisted of 145 individuals with CHR who completed a 5-year follow-up with a confirmed transition to psychosis within this period. Clinical variables along with functional variables such as the Global Assessment of Function (GAF) score at baseline (GAF baseline) and GAF-drop from the highest score in the past year. The TCP was defined as the duration from CHR identification to psychosis conversion. Participants were categorized into 3 groups based on TCP: "short" (≤6 months, ≤33.3%), "median" (7-17 months, 33.3%-66.6%), and "long" (≥18 months, ≥66.6%). The quantile regression analysis was applied. Study results: The overall sample had a median TCP of 11 months. Significant differences among the three TCP groups were observed, particularly in GAF-drop (χ2 = 8.806, P = .012), disorganized symptoms (χ2 = 7.071, P = .029), and general symptoms (χ2 = 6.586, P = .037). Greater disorganized symptoms (odds ratio [OR] = 0.824, P = .009) and GAF-drop (OR = 0.867, P = .011) were significantly associated with a shorter TCP, whereas greater general symptoms (OR = 1.198, P = .012) predicted a longer TCP. Quantile regression analysis demonstrated a positive association between TCP and GAF baseline above the 0.7 quantile and a negative association between TCP rank and GAF drop below the 0.5 quantile. Conclusions: This study underscores the pivotal role of functional characteristics in shaping TCP among individuals with CHR, emphasizing the necessity for a comprehensive consideration of temporal aspects in early prevention efforts.
Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis

Jessica P Y Hua,Samantha V Abram,Rachel L Loewy,Barbara Stuart,Susanna L Fryer,Sophia Vinogradov,Daniel H Mathalon

DOI: https://doi.org/10.1093/schbul/sbae074

2024-08-27

Abstract:Background and hypothesis: Brain development/aging is not uniform across individuals, spawning efforts to characterize brain age from a biological perspective to model the effects of disease and maladaptive life processes on the brain. The brain age gap represents the discrepancy between estimated brain biological age and chronological age (in this case, based on structural magnetic resonance imaging, MRI). Structural MRI studies report an increased brain age gap (biological age > chronological age) in schizophrenia, with a greater brain age gap related to greater negative symptom severity. Less is known regarding the nature of this gap early in schizophrenia (ESZ), if this gap represents a psychosis conversion biomarker in clinical high-risk (CHR-P) individuals, and how altered brain development and/or aging map onto specific symptom facets. Study design: Using structural MRI, we compared the brain age gap among CHR-P (n = 51), ESZ (n = 78), and unaffected comparison participants (UCP; n = 90), and examined associations with CHR-P psychosis conversion (CHR-P converters n = 10; CHR-P non-converters; n = 23) and positive and negative symptoms. Study results: ESZ showed a greater brain age gap relative to UCP and CHR-P (Ps < .010). CHR-P individuals who converted to psychosis showed a greater brain age gap (P = .043) relative to CHR-P non-converters. A larger brain age gap in ESZ was associated with increased experiential (P = .008), but not expressive negative symptom severity. Conclusions: Consistent with schizophrenia pathophysiological models positing abnormal brain maturation, results suggest abnormal brain development is present early in psychosis. An increased brain age gap may be especially relevant to motivational and functional deficits in schizophrenia.
Environmental and psychopathological predictors of clinical high‐risk of psychosis in adolescence

Inma Fernández,Maria Juncal‐Ruiz,Ana María González‐Menéndez,Mercedes Paino

DOI: https://doi.org/10.1002/jclp.23723

2024-06-07

Journal of Clinical Psychology

Abstract:Objectives Clinical high‐risk psychosis (CHRp) samples can be heterogeneous, consisting essentially of people with not only psychotic‐like experiences but also nonspecific symptoms that may reflect common mental disorders such as depression, anxiety, or substance abuse pathologies. Few studies have attempted to analyze and understand psychosis risk in relation to both environmental (ER) and psychopathological risk (PsR) factors. This study aimed to determine the clinical risk of psychosis in adolescents. Methods A representative sample of 1824 Spanish adolescents from the general population was evaluated using different scales to thoroughly examine the possible interaction of CHRp with various ER and PsR factors. Partial correlations were calculated to assess the relationships between the variables. A series of hierarchical linear regression models were then used to obtain a CHRp predictor model. Results The CHRp predictor model indicated that PsR was the most significant determining factor, explaining 22% of the total associated variance of CHRp. However, the ER factor also emerged as a significant predictor of high‐risk psychosis (accounting for 9% of the variance). Conclusions A predictive model for CHRp in adolescents was found, in which common psychological problems were presented as more determinant risk factors than ER disruptors. Furthermore, certain transdiagnostic processes, such as psychological inflexibility, may play a central role in the development of mental health problems, including psychosis. Specifying the mechanisms underlying the emergence of CHRp in adolescence is the key to optimizing the focus of preventive therapeutic interventions in these early stages.

psychology, clinical
Cognitive subtypes in youth at clinical high risk for psychosis

Walid Yassin,James Green,Matcheri Keshavan,Elisabetta C. del Re,Jean Addington,Carrie E Bearden,Kristin S Cadenhead,Tyrone D Cannon,Barbara A Cornblatt,Daniel H Mathalon,Diana O Perkins,Elaine F Walker,Scott W Woods,William S Stone

DOI: https://doi.org/10.1101/2024.08.07.24311240

2024-08-08

Abstract:Abstract Introduction Schizophrenia is a mental health condition that severely impacts well-being. Cognitive impairment is among its core features, often presenting well before the onset of psychosis, underscoring a critical need to study it in the psychosis proneness stage, to maximize the benefits of interventions and to improve clinical outcomes. However, given the heterogeneity of cognitive impairment in this population, a one-size-fits-all approach to therapeutic interventions would likely be insufficient. Thus, identifying cognitive subtypes in this population is crucial for tailored and successful therapeutic interventions. Here we identify, validate, and characterize cognitive subtypes in large CHR samples and delineate their baseline and longitudinal cognitive and functional trajectories. Methods Using machine learning, we performed cluster analysis on cognitive measures in a large CHR sample (CHR (n = 764) HC (n = 280)) from the North American Prodrome Longitudinal Study (NAPLS) 2, and independently validated our findings with an equally large sample using NAPLS 3. By utilizing several statistical approaches, we compared the clusters on cognition and functioning at baseline, and longitudinally. We further delineate the conversion status within those clusters. Results Two main cognitive clusters were identified, impaired and intact across all cognitive domains compared to controls. The differences at baseline between the cognitively intact cluster and controls were found in the verbal abilities and attention and working memory domains. Longitudinally, those in the cognitively impaired cluster group demonstrated an overall floor effect and did not deteriorate further over time. However, a catch up trajectory was observed in the attention and working memory domain. This group had higher instances of conversion overall, with these converters having significantly more psychotic disorder diagnosis versus bipolar disorder, than those with intact cognition. In the cognitively intact group, we observed differences in the trajectory based on their conversion status, where those who start with intact cognition and later convert, demonstrate a sharp decline in attention and functioning. Functioning was significantly better in the cognitively intact than in the impaired group at baseline. Most of the cognitive trajectories demonstrate a meaningful positive relationship with functional ones. Conclusion Our findings provide evidence for intact and impaired cognitive subtypes in youth at CHR, independent of their conversion status. They further indicate that attention and working memory are important to distinguish between the CHR with intact cognition and controls. The cognitively intact CHR group becomes less attentive after conversion, while the cognitively impaired one demonstrates a catch up trajectory on both attention and working memory. Overall, early evaluation, covering several cognitive domains, is crucial for identifying trajectories of improvement and deterioration for the purpose of tailoring intervention for improving outcomes in individuals at CHR for psychosis.

Psychiatry and Clinical Psychology
Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra‐high risk in the UHR 1000+ cohort

Simon Hartmann,Dominic Dwyer,Blake Cavve,Enda M. Byrne,Isabelle Scott,Caroline Gao,Cassandra Wannan,Hok Pan Yuen,Jessica Hartmann,Ashleigh Lin,Stephen J. Wood,Johanna T.W. Wigman,Christel M. Middeldorp,Andrew Thompson,Paul Amminger,Monika Schlögelhofer,Anita Riecher‐Rössler,Eric Y.H. Chen,Ian B. Hickie,Lisa J. Phillips,Miriam R. Schäfer,Nilufar Mossaheb,Stefan Smesny,Gregor Berger,Lieuwe de Haan,Merete Nordentoft,Swapna Verma,Dorien H. Nieman,Patrick D. McGorry,Alison R. Yung,Scott R. Clark,Barnaby Nelson

DOI: https://doi.org/10.1002/wps.21240

2024-09-16

World Psychiatry

Abstract:The concept of ultra‐high risk for psychosis (UHR) has been at the forefront of psychiatric research for several decades, with the ultimate goal of preventing the onset of psychotic disorder in high‐risk individuals. Orygen (Melbourne, Australia) has led a range of observational and intervention studies in this clinical population. These datasets have now been integrated into the UHR 1000+ cohort, consisting of a sample of 1,245 UHR individuals with a follow‐up period ranging from 1 to 16.7 years. This paper describes the cohort, presents a clinical prediction model of transition to psychosis in this cohort, and examines how predictive performance is affected by changes in UHR samples over time. We analyzed transition to psychosis using a Cox proportional hazards model. Clinical predictors for transition to psychosis were investigated in the entire cohort using multiple imputation and Rubin's rule. To assess performance drift over time, data from 1995‐2016 were used for initial model fitting, and models were subsequently validated on data from 2017‐2020. Over the follow‐up period, 220 cases (17.7%) developed a psychotic disorder. Pooled hazard ratio (HR) estimates showed that the Comprehensive Assessment of At‐Risk Mental States (CAARMS) Disorganized Speech subscale severity score (HR=1.12, 95% CI: 1.02‐1.24, p=0.024), the CAARMS Unusual Thought Content subscale severity score (HR=1.13, 95% CI: 1.03‐1.24, p=0.009), the Scale for the Assessment of Negative Symptoms (SANS) total score (HR=1.02, 95% CI: 1.00‐1.03, p=0.022), the Social and Occupational Functioning Assessment Scale (SOFAS) score (HR=0.98, 95% CI: 0.97‐1.00, p=0.036), and time between onset of symptoms and entry to UHR service (log transformed) (HR=1.10, 95% CI: 1.02‐1.19, p=0.013) were predictive of transition to psychosis. UHR individuals who met the brief limited intermittent psychotic symptoms (BLIPS) criteria had a higher probability of transitioning to psychosis than those who met the attenuated psychotic symptoms (APS) criteria (HR=0.48, 95% CI: 0.32‐0.73, p=0.001) and those who met the Trait risk criteria (a first‐degree relative with a psychotic disorder or a schizotypal personality disorder plus a significant decrease in functioning during the previous year) (HR=0.43, 95% CI: 0.22‐0.83, p=0.013). Models based on data from 1995‐2016 displayed good calibration at initial model fitting, but showed a drift of 20.2‐35.4% in calibration when validated on data from 2017‐2020. Large‐scale longitudinal data such as those from the UHR 1000+ cohort are required to develop accurate psychosis prediction models. It is critical to assess existing and future risk calculators for temporal drift, that may reduce their utility in clinical practice over time.

psychiatry
Longitudinal Changes in Cortical Surface Area Associated With Transition to Psychosis in Adolescents at Clinical High Risk for the Disease

Adriana Fortea,Philip van Eijndhoven,Daniel Ilzarbe,Albert Batalla,Angels Calvet-Mirabent,Elena de la Serna,Olga Puig,Josefina Castro-Fornieles,Montserrat Dolz,Jordina Tor,Sara Parrilla,Esther Via,Christian Stephan-Otto,Inmaculada Baeza,Gisela Sugranyes

DOI: https://doi.org/10.1016/j.jaac.2023.01.001

Abstract:Objective: Identifying biomarkers of transition to psychosis in individuals at clinical high risk for psychosis (CHR-P) is essential to understanding the mechanisms underlying the disease. Although cross-sectional abnormalities in cortical surface area (CSA) have been demonstrated in individuals at CHR-P who transition to psychosis (CHR-P-T) compared with those who do not (CHR-P-NT), how CSA longitudinally develops remains unclear, especially in younger individuals. We set out to compare CSA in adolescents at CHR-P and healthy controls (HC) over 2 points in time. Method: A longitudinal multicenter study was performed in adolescents at CHR-P in comparison to HC and according to transition to psychosis. Magnetic resonance imaging scans were acquired at baseline, at 18-month follow-up, or at the time of transition. Images were pre-processed and hemisphere and regional CSA were computed using FreeSurfer. Between-group analyses were performed with linear mixed-effects models. Results: A total of 313 scans (107 CHR-P and 102 HC) were included in the analysis. At 18 months, the rate of transition to psychosis in CHR-P was 23.4%. Adolescents at CHR-P-T presented greater age-related decrease in CSA in the left parietal and occipital lobes compared with HC, and in the bilateral parietal lobe and right frontal lobe relative to CHR-P-NT. These results were not influenced by antipsychotic treatment, cannabis use, or intelligence quotient (IQ). Conclusion: Adolescents at CHR-P that developed a psychotic disorder presented different developmental trajectories of CSA relative to those who did not. A relatively greater decrease in CSA in the parietal and frontal lobes may index clinical transition to psychosis in adolescents at CHR-P.
Factorial structure of the Comprehensive Assessment of At-Risk Mental States in help-seeking individuals: mapping the structure and the prediction of subsequent transition to psychosis

Cristiana Montemagni,Anna Carluccio,Claudio Brasso,Flavio Vischia,Paola Rocca

DOI: https://doi.org/10.3389/fpsyt.2024.1381133

IF: 4.7

2024-05-25

Frontiers in Psychiatry

Abstract:Objectives: The aim of the current study was 3-fold: 1) to examine the factorial structure of the Comprehensive Assessment of At-Risk Mental States (CAARMS) in help-seeking individuals undergoing an assessment on suspicion of psychosis risk; 2) to investigate the association of CAARMS factors with functioning; 3) and to test the association of any derived factors with the longitudinal outcome of transition to psychosis. Methods: The study included 101 patients. First, a principal component analysis (PCA) was conducted using the Varimax rotation method. A minimum initial eigenvalues of greater than or equal to 1.0, analysis of Scree plots, percentage of variance explained by each component, reliability (Cronbach's alpha) of factors above 0.7 and Parallel Analysis were the criteria used to determine the appropriate number of factors Second, Spearman correlations were run to analyze the relationship between CAARMS factors and sociodemographic and functional variables (i.e. age, schooling, Social and Occupational Functioning Assessment Scale-SOFAS- and Health of the Nation Outcome Scales-HoNOS- scores). Third, we performed a Logistic regression analysis to evaluate the association between baseline CAARMS factors and the risk of transition to psychosis at the 6-month follow-up. Results: A total of 101 consecutive patiens were recruited. We found that: 1) a 6 factor model solution as the most appropriate, jointly accounting for 65% of the variance; 2) factors 1 ("negative-interpersonal"), 2 ("cognitive-disorganization"), 3 ("positive"), and 4 ("motor-physical changes") were negatively correlated with SOFAS total score; factors 1, 2, and 3 showed positive correlations with HoNOS total score; factors 2 and 3 present similar patterns of correlations, factor 3 manifesting the strongest association with HoNOS symptoms, HONOS and SOFAS total score. Both factors 5 and 6 show significant associations with HoNOS behavioral impairment; 3) after 6 months 28 participants (30.1%) converted to psychosis. Factors 2 and 3 were positively associated with the risk of transition to psychosis; whereas, the factor 5 ("affective factor") was negatively associated with the outcome variable. Conclusions: It is thus crucial to recognize the type and severity of psychopathology in help-seeking individuals in order to intensive clinical monitoring of subclinical psychopathology risk profiles, and design specific care pathways.

psychiatry
White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis

Maria A. Di Biase,Suheyla Cetin-Karayumak,Amanda E. Lyall,Andrew Zalesky,Kang Ik Kevin Cho,Fan Zhang,Marek Kubicki,Yogesh Rathi,Monica G. Lyons,Sylvain Bouix,Tashrif Billah,Alan Anticevic,Charlie Schleifer,Brendan D. Adkinson,Jie Lisa Ji,Zailyn Tamayo,Jean Addington,Carrie E. Bearden,Barbara A. Cornblatt,Matcheri S. Keshavan,Daniel H. Mathalon,Thomas H. McGlashan,Diana O. Perkins,Kristen S. Cadenhead,Ming T. Tsuang,Scott W. Woods,William S. Stone,Martha E. Shenton,Tyrone D. Cannon,Ofer Pasternak

DOI: https://doi.org/10.1038/s41380-021-01128-8

IF: 11

2021-05-24

Molecular Psychiatry

Abstract:Subtle alterations in white matter microstructure are observed in youth at clinical high risk (CHR) for psychosis. However, the timing of these changes and their relationships to the emergence of psychosis remain unclear. Here, we track the evolution of white matter abnormalities in a large, longitudinal cohort of CHR individuals comprising the North American Prodrome Longitudinal Study (NAPLS-3). Multi-shell diffusion magnetic resonance imaging data were collected across multiple timepoints (1–5 over 1 year) in 286 subjects (aged 12–32 years): 25 CHR individuals who transitioned to psychosis (CHR-P; 61 scans), 205 CHR subjects with unknown transition outcome after the 1-year follow-up period (CHR-U; 596 scans), and 56 healthy controls (195 scans). Linear mixed effects models were fitted to infer the impact of age and illness-onset on variation in the fractional anisotropy of cellular tissue (FAT) and the volume fraction of extracellular free water (FW). Baseline measures of white matter microstructure did not differentiate between HC, CHR-U and CHR-P individuals. However, age trajectories differed between the three groups in line with a developmental effect: CHR-P and CHR-U groups displayed higher FAT in adolescence, and 4% lower FAT by 30 years of age compared to controls. Furthermore, older CHR-P subjects (20+ years) displayed 4% higher FW in the forceps major (p < 0.05). Prospective analysis in CHR-P did not reveal a significant impact of illness onset on regional FAT or FW, suggesting that transition to psychosis is not marked by dramatic change in white matter microstructure. Instead, clinical high risk for psychosis—regardless of transition outcome—is characterized by subtle age-related white matter changes that occur in tandem with development.

biochemistry & molecular biology,neurosciences,psychiatry
Case report: From anxiety disorders to psychosis, a continuum in transitional age youth?

Joana Reis,Simone Marchini,Hélène Nicolis,Véronique Delvenne

DOI: https://doi.org/10.3389/fpsyt.2022.990138

IF: 4.7

2022-10-04

Frontiers in Psychiatry

Abstract:Introduction: To date, among individuals meeting ultra-high risk criteria for psychosis, the relationship between the presence of anxiety disorders and the risk of psychotic transition raises several unanswered questions. Case description: This case report describes the clinical progression of a 17-year-old male initially presenting anxious symptoms meeting the DSM-V criteria for panic disorder. The patient also reported social withdraw, mild depressive symptoms, insomnia and fatigue. Over a 6 month period, a gradual onset of subthreshold psychotic symptoms suggested a prodromal phase of a psychotic disorder. Diagnostic assessment and therapeutic intervention: A detailed assessment of UHR criteria for psychosis was performed. The overall level of social and occupational functioning was assessed by the SOFAS, which showed a 35% drop over a 12 months period. The CAARMS, has also been administered. The patient met the diagnostic criteria for UHR, APS group. The care plan included psychiatric follow-up, pharmacologic treatment, individual psychological follow-up and individual and familial psychoeducation. Over a 6 months period, the patient did not experienced a first psychotic episode and presented a partial improvement of psychotic symptoms. Conclusion: The DSM-V categorical approach does not seem to adapt well to early clinical presentations in transitional age youth. A transdiagnostic and dimensional approach allows to better identify at-risk patients of psychiatric disorders and implement early intervention strategies.

psychiatry
Identification of distinct clinical profiles and trajectories in individuals at high risk of developing psychosis: A latent profile analysis of the north American prodrome longitudinal study consortium‐3 dataset

Daniel Bergé,Cameron S. Carter,Jason Smucny

DOI: https://doi.org/10.1111/eip.13514

2024-02-15

Early Intervention in Psychiatry

Abstract:Aim People at clinical high risk (CHR) for psychosis are a heterogeneous population in regard to clinical presentation and outcome. It is unclear, however, if their baseline clinical characteristics can be used to construct orthogonal subgroups that differ in their clinical trajectory to provide early identification of individuals in need of tailored interventions. Methods We used latent profile analysis (LPA) to determine the number of distinct clinical profiles within the CHR population using the NAPLS‐3 dataset, focusing on the clinical features incorporated in the NAPLS psychosis risk calculator (including age, unusual thought content and suspiciousness, processing speed, verbal learning and memory function, social functioning decline, life events, childhood trauma, and family history of psychosis). We then conducted a between‐profile comparisons of clinical trajectories based on psychotic and depressive symptoms as well as substance use disorder (SUD) related features over time. Results Two distinct profiles emerged. One profile, comprising approximately 25% of the sample, was significantly older, displayed better cognitive performance, experienced more types of traumatic and undesirable life events, exhibited a greater decline in functioning in the past year, and was more likely to have relatives with psychosis. This group showed worse positive symptoms and SUD‐related features over time, although groups did not differ in the proportion of individuals who developed psychosis. Conclusions LPA results suggest CHRs can be segregated into two profiles with different clinical trajectories. Characterizing individuals within these clinical profiles may help understand the divergent outcomes of this population and ultimately facilitate the development of specialized interventions.

psychiatry
Low-energy collision-induced dissociation tandem mass spectrometry of 7-acetonyloxycoumarins.

Juri M. Timonen,Ritva Romppanen,P. Aulaskari,J. Jänis

DOI: https://doi.org/10.1002/rcm.6735

IF: 2.586

2013-12-15

Rapid Communications in Mass Spectrometry

Abstract:RATIONALE Coumarins are naturally occurring, oxygen-containing heterocycles with considerable pharmaceutical potential. For structural elucidation of natural or synthetic coumarins, tandem mass spectrometry (MS(n)) represents an essential tool. In this study, fragmentation characteristics of twenty-two 7-acetonyloxycoumarins, having promising anti-inflammatory properties, were investigated with low-energy collision-induced dissociation (CID). METHODS Accurate mass measurements were performed on a 12-T Fourier transform ion cyclotron resonance (FT-ICR) instrument. Most CID-MS(n) measurements were performed on a quadrupole ion trap (QIT) instrument, except some additional CID-MS(2) measurements performed on the FT-ICR instrument for further confirmation of some fragment ions. Positive-ion electrospray ionization (ESI) was employed throughout. Density functional theory (DFT) calculations (B3LYP) were carried out to analyze putative ion structures/fragmentation channels. RESULTS The most favourable dissociation channel for [M + H](+) ions of 7-acetonyloxycoumarins was the elimination of a C3H5O(●) radical (57 Da) from the 7-acetonyloxy group via homolytic bond cleavage. The resulting phenolic radical ion was the primary fragment ion for the most compounds studied. Losses of even-electron neutrals, C3H4O and C3H6O (56 and 58 Da), were also observed. These primary eliminations were accompanied with other characteristic neutral losses from the coumarin skeleton, including H2O, CO, CO2, and C2H2O (ketene). In addition, propene (C3H6) loss was also observed for 4-propyl or 3-ethyl-4-methyl-substituted compounds. CONCLUSIONS The studied coumarins showed interesting characteristics in low-energy CID due to the presence of a 7-acetonyloxy group, leading to both even- and odd-electron product ions. The main dissociation channels observed for each compound were highly dependent on the substituents in the benzopyranone ring. The present results will advance our knowledge on the dissociation characteristics of both synthetic and natural coumarins.

p-Aminosalicylic acid in tuberculosis.

Thinner cortex is associated with psychosis onset in individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group mega-analysis

Association of Structural Magnetic Resonance Imaging Measures with Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: an ENIGMA Working Group Mega-analysis.

Clinical and neurodevelopmental predictors of psychotic disorders in children and adolescents at clinical high risk for psychosis: the CAPRIS study

Free Long-Acting Injectables for Patients with Psychosis: A Step Forward.

Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program

Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?

Symptom Dimensions and Cognitive Impairments in Individuals at Clinical High Risk for Psychosis

Proteomic Biomarkers for the Prediction of Transition to Psychosis in Individuals at Clinical High Risk: A Multi-cohort Model Development Study

Neurocognitive profiles in the prodrome to psychosis in NAPLS-1

Timeframe for Conversion to Psychosis From Individuals at Clinical High-Risk: A Quantile Regression

Brain Age Gap in Early Illness Schizophrenia and the Clinical High-Risk Syndrome: Associations With Experiential Negative Symptoms and Conversion to Psychosis

Environmental and psychopathological predictors of clinical high‐risk of psychosis in adolescence

Cognitive subtypes in youth at clinical high risk for psychosis

Development and temporal validation of a clinical prediction model of transition to psychosis in individuals at ultra‐high risk in the UHR 1000+ cohort

Longitudinal Changes in Cortical Surface Area Associated With Transition to Psychosis in Adolescents at Clinical High Risk for the Disease

Factorial structure of the Comprehensive Assessment of At-Risk Mental States in help-seeking individuals: mapping the structure and the prediction of subsequent transition to psychosis

White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis

Case report: From anxiety disorders to psychosis, a continuum in transitional age youth?

Identification of distinct clinical profiles and trajectories in individuals at high risk of developing psychosis: A latent profile analysis of the north American prodrome longitudinal study consortium‐3 dataset

Low-energy collision-induced dissociation tandem mass spectrometry of 7-acetonyloxycoumarins.